CHEST 2023 On Demand Pass-Pro/Con Debate: Biologics Should be Used for All Patients Requiring ICS ‚Äì Canadian Thoracic Society (CTS)

Pro/Con Debate: Biologics Should be Used for All Patients Requiring ICS ‚Äì Canadian Thoracic Society (CTS)

Video Transcription

Video Summary

This transcript is from a pro-con debate on the topic of whether biologics should be used for all patients requiring inhaled corticosteroids (ICS) in the treatment of asthma. The pro side argues that inhaled steroids are outdated and that biologics should be used early in asthma management to prevent long-term damage and improve quality of life. They provide examples of patients whose lives have been transformed by biologic treatments. The con side argues that biologics have limited efficacy, with studies showing no clinical improvements in non-severe asthmatics. They also argue that the high cost of biologics and the potential for misdiagnosis make them an impractical and costly solution. Ultimately, the audience is asked to vote on which side made a more convincing argument.

Meta Tag

Session ID 2167

Speaker Krystelle Godbout

Speaker Christopher Hergott

Speaker Pierre Landry

Track Procedures

Keywords

biologics

asthma

treatment

outdated

long-term damage

quality of life

efficacy